These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6117467)

  • 1. Hemodynamic effects of strophanthin and pindolol in patients with hypertrophic cardiomyopathy.
    Storstein L; Abrahamsen AM; Storstein O
    Eur Heart J; 1981 Aug; 2(4):297-305. PubMed ID: 6117467
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of practolol, propranolol and strophanthin compared with placebo on exercise tolerance and a postural test in patients with hypertrophic cardiomyopathy.
    Storstein L; Amlie JP
    Eur Heart J; 1981 Aug; 2(4):289-96. PubMed ID: 6117466
    [No Abstract]   [Full Text] [Related]  

  • 3. [Systolic times of the left ventricle in hypertrophic obstructive cardiomyopathy: effects of beta-adrenergic stimulation and blocking].
    Giovannini E; Ferrari O; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(11):1595-600. PubMed ID: 1241953
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of cardiomyopathies from a pathophysiological viewpoint].
    Inoo T; Yokota Y
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):226-30. PubMed ID: 8098349
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
    Boissier JR; Coutte R; Advenier C; Giudicelli JF
    Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy.
    Cooper M; Shaddy R; Silverman N; Enderlein M
    Am J Cardiol; 1985 Jul; 56(1):201-2. PubMed ID: 4040320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic effects of some beta-adrenergic blocking agents in conscious spontaneously hypertensive rats (author's transl)].
    Matsunaga K; Ueda M
    Nihon Yakurigaku Zasshi; 1981 Jun; 77(6):597-604. PubMed ID: 6116655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pindolol in pediatrics. Evaluation of cardiac haemodinamics (author's transl)].
    Antoncecchi E; Mollica N; Ranieri L; Tagliente MR; Antoncecchi E
    Pediatr Med Chir; 1981; 3(6):551-4. PubMed ID: 6123984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive and hemodynamic effects of beta-receptor blockaders with various action spectra].
    Lohmöller G; Lydtin H; Frohlich ED
    Adv Clin Pharmacol; 1976; 11():94-8. PubMed ID: 25572
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic examinations concerning the effects of cardiac glycosides in hypertrophic obstructive cardiomyopathy (HOCM)].
    Assmann I; Fiehring H; Oltmanns G; Dittrich P; Basche S; Strauss HJ
    Z Kardiol; 1982 Jul; 71(7):473-9. PubMed ID: 6890276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis.
    BRAUNWALD E; BROCKENBROUGH EC; FRYE RL
    Circulation; 1962 Aug; 26():166-73. PubMed ID: 13872647
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodynamic effects of beta blockade in hypertrophic cardiomyopathy using Sectral (acebutolol; M and B 17803A).
    Lewis BS; Mitha AS; Bakst A; Purdon K; Gotsman MS
    Cardiovasc Res; 1974 Mar; 8(2):249-62. PubMed ID: 4150819
    [No Abstract]   [Full Text] [Related]  

  • 19. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
    Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
    Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.